Ceribell, Inc.
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
CBLL$27.60+3.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Cash Flows
(in thousands)
| Year ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities | ||
| Net loss | $(53,412) | $(40,455) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization expense | 1,341 | 1,141 |
| Noncash lease expense | (101) | 59 |
| Stock-based compensation expense | 12,223 | 5,411 |
| Amortization of debt discount and accretion of premium on term loans | 415 | 382 |
| Accretion (amortization) of discount and premium on marketable securities | (2,011) | — |
| Change in fair value of warrant liability | — | 1,496 |
| Loss on disposal of property and equipment and recorders | 104 | 95 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable, net | (4,175) | (2,923) |
| Inventory | (351) | (1,068) |
| Prepaid expenses and other current assets | 345 | (1,121) |
| Contract costs | (713) | (591) |
| Other non-current asset | (415) | (65) |
| Accounts payable | 1,745 | 250 |
| Accrued liabilities and other current liabilities | 4,223 | 2,469 |
| Contract liabilities | (26) | (123) |
| Net cash used in operating activities | (40,808) | (35,043) |
| Cash flows from investing activities | ||
| Purchases of recorder components and recorders | (755) | (258) |
| Purchases of property and equipment | (767) | (1,340) |
| Purchases of marketable securities | (210,815) | — |
| Proceeds from maturities of marketable securities | 94,200 | — |
| Net cash used in investing activities | (118,137) | (1,598) |
| Cash flows from financing activities | ||
| Proceeds related to employee stock plans | 5,437 | 1,129 |
| Taxes withheld and paid related to settlement or vesting of equity awards | (236) | — |
| Proceeds from debt issuance | — | 7,905 |
| Debt issuance cost | (150) | (304) |
| Payment of deferred IPO offering costs | — | (5,048) |
| Proceeds from IPO, net of commissions | — | 192,834 |
| Net cash provided by financing activities | 5,051 | 196,516 |
| Net increase (decrease) in cash and cash equivalents | (153,894) | 159,875 |
| Cash and cash equivalents, beginning of period | 194,370 | 34,495 |
| Cash and cash equivalents, end of period | $40,476 | $194,370 |
| Supplemental disclosure of cash flow information | ||
| Cash paid for interest | $1,894 | $1,952 |
| Right-of-use asset obtained in exchange for operating lease obligation | 1,142 | 778 |
| Property and equipment included in accounts payable and accrued expenses | 63 | 99 |
| Recorder components included in accounts payable and accrued expenses | 67 | 69 |
| Conversion of redeemable convertible preferred stock into common stock on completion of IPO | — | 147,412 |
Ceribell, Inc.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.